Companies: 10,795·Total market cap: $144.5T

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc.

ONCTNASDAQHealthcare

$0.53

$-0.17(-24.12%)

Market Cap$1558546

P/E Ratio—

52W High$10.613

52W Low$0.5266

Avg Volume62K

Open$0.70

Beta1.36

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Oncternal Therapeutics, Inc.（ONCT）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ONCT · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Oncternal Therapeutics, Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Oncternal Therapeutics, Inc.

$0.53-24.12%$1.6M #2

ASLAN Pharmaceuticals Limited

$0.60-14.27%$194.3M #3

$0.47-20.74%$1.5M #4

$0.42+100.00%$1.6M #5

$0.41+0.00%$1.2M #6

NeuBase Therapeutics, Inc.

$0.38-1.56%$1.4M

关于 Oncternal Therapeutics, Inc.

CEOJames B. Breitmeyer

IPO DateFeb 3, 2004

Employees27

CountryUS

Websiteoncternal.com

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating cancer treatments for diseases where current medical options are insufficient. Its clinical-stage portfoli…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Oncternal Therapeutics, Inc.（ONCT）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 3, 2004 在 NASDAQ 上市。截至最近交易日，ONCT 股价为 $0.53，市值约为 $1.6M。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Oncternal Therapeutics, Inc.（ONCT）股价为 $0.53，在 NASDAQ 上市，52周区间为 $0.53 – $10.61。

ONCT 最新股价ONCT quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议